EE200000625A - Atsetüülkoliinkoostiste stabiliseerimise meetodidja koostised - Google Patents

Atsetüülkoliinkoostiste stabiliseerimise meetodidja koostised

Info

Publication number
EE200000625A
EE200000625A EEP200000625A EEP200000625A EE200000625A EE 200000625 A EE200000625 A EE 200000625A EE P200000625 A EEP200000625 A EE P200000625A EE P200000625 A EEP200000625 A EE P200000625A EE 200000625 A EE200000625 A EE 200000625A
Authority
EE
Estonia
Prior art keywords
acetylcholine
compositions
buffered
stabilizing
product
Prior art date
Application number
EEP200000625A
Other languages
English (en)
Inventor
Tsao Fu-Pao
Edward Minno George
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of EE200000625A publication Critical patent/EE200000625A/et
Publication of EE04515B1 publication Critical patent/EE04515B1/et

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polymerisation Methods In General (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EEP200000625A 1998-04-29 1999-04-27 Atsetlkoliinkoostiste stabiliseerimise meetodidja koostised EE04515B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6955298A 1998-04-29 1998-04-29
PCT/EP1999/002846 WO1999055304A1 (en) 1998-04-29 1999-04-27 Methods and compositions for stabilizing acetylcholine compositions

Publications (2)

Publication Number Publication Date
EE200000625A true EE200000625A (et) 2002-02-15
EE04515B1 EE04515B1 (et) 2005-08-15

Family

ID=22089751

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000625A EE04515B1 (et) 1998-04-29 1999-04-27 Atsetlkoliinkoostiste stabiliseerimise meetodidja koostised

Country Status (24)

Country Link
US (1) US6261546B1 (et)
EP (1) EP1073413B1 (et)
JP (1) JP2002512945A (et)
KR (1) KR100617429B1 (et)
CN (1) CN1147289C (et)
AT (1) ATE286380T1 (et)
AU (1) AU745124B2 (et)
BR (1) BR9910077A (et)
CA (1) CA2327398C (et)
CZ (1) CZ301969B6 (et)
DE (1) DE69923063T2 (et)
EE (1) EE04515B1 (et)
ES (1) ES2235486T3 (et)
HU (1) HU226104B1 (et)
ID (1) ID26032A (et)
IL (1) IL138775A0 (et)
NO (1) NO20005372D0 (et)
NZ (1) NZ507074A (et)
PL (1) PL194092B1 (et)
PT (1) PT1073413E (et)
RU (1) RU2225199C2 (et)
SI (1) SI1073413T1 (et)
UA (1) UA72209C2 (et)
WO (1) WO1999055304A1 (et)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2670436A1 (en) 2006-11-30 2008-06-05 Nihon Medi-Physics Co., Ltd. Novel compound having affinity for amyloid
US20130029919A1 (en) 2011-07-26 2013-01-31 Allergan, Inc. Two part formulation system for opthalmic delivery

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5009892A (en) * 1989-03-03 1991-04-23 Mckinzie James W Rapid miosis with control of intraocular pressure
RU2056821C1 (ru) * 1993-02-26 1996-03-27 Межотраслевой научно-технический комплекс "Микрохирургия глаза" Глазные капли "кератоник"
RU2100020C1 (ru) * 1993-06-23 1997-12-27 Лейрас Ой Средство для местного лечения глазной гипертензии и глаукомы и способ его получения
US5565188A (en) 1995-02-24 1996-10-15 Nanosystems L.L.C. Polyalkylene block copolymers as surface modifiers for nanoparticles
US5612027A (en) 1995-04-18 1997-03-18 Galin; Miles A. Controlled release of miotic and mydriatic drugs in the anterior chamber

Also Published As

Publication number Publication date
CA2327398C (en) 2008-12-30
ID26032A (id) 2000-11-16
EE04515B1 (et) 2005-08-15
NZ507074A (en) 2004-02-27
CZ20003961A3 (cs) 2001-01-17
NO20005372L (no) 2000-10-25
CA2327398A1 (en) 1999-11-04
WO1999055304A1 (en) 1999-11-04
BR9910077A (pt) 2000-12-26
KR100617429B1 (ko) 2006-08-30
HK1034204A1 (en) 2001-10-19
EP1073413B1 (en) 2005-01-05
NO20005372D0 (no) 2000-10-25
AU4034099A (en) 1999-11-16
PL194092B1 (pl) 2007-04-30
RU2225199C2 (ru) 2004-03-10
EP1073413A1 (en) 2001-02-07
ATE286380T1 (de) 2005-01-15
AU745124B2 (en) 2002-03-14
HUP0100613A2 (hu) 2001-08-28
PL343174A1 (en) 2001-07-30
UA72209C2 (en) 2005-02-15
JP2002512945A (ja) 2002-05-08
IL138775A0 (en) 2001-10-31
HUP0100613A3 (en) 2001-12-28
DE69923063D1 (de) 2005-02-10
CN1147289C (zh) 2004-04-28
CN1298295A (zh) 2001-06-06
PT1073413E (pt) 2005-04-29
DE69923063T2 (de) 2005-12-22
US6261546B1 (en) 2001-07-17
SI1073413T1 (et) 2005-08-31
KR20010043121A (ko) 2001-05-25
ES2235486T3 (es) 2005-07-01
HU226104B1 (en) 2008-04-28
CZ301969B6 (cs) 2010-08-18

Similar Documents

Publication Publication Date Title
DE69617273D1 (de) Heterocyclisch substituierte cyclopentanderivate.
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
TR199903331T2 (xx) Farnesil protein transferas engelleyicileri.
ATE177420T1 (de) Cyclobutan-derivate als inhibitoren der squalen- synthetase und der protein-farnesyltransferase
ATE173630T1 (de) Behandlung von entzündlichen darmerkrankungen mit interferon-gamma-inhibitoren
CA2200195A1 (en) Use of aromatase inhibitors for the production of a pharmaceutical agentfor treating a relative androgen deficiency in men
WO2002008217A3 (en) COUMARIN DERIVATIVES USEFUL AS TNFα INHIBITORS
DK1273299T3 (da) Minoxidilinindeholdende praparater
JO1696B1 (en) Acetamide derivatives
YU78202A (sh) Tečne formulacije
DE69625354D1 (de) Relaxinartiger faktor und damit zusammenhängende verfahren und verwendungen
WO2002028829A3 (en) Peptide deformylase inhibitors
WO2001087287A3 (en) Use of pyrazole derivatives for treating infertility
ES2111272T3 (es) Mezclas herbicidas.
ATE204851T1 (de) Verfahren zur herstellung von retrovial protease hemmenden zwischenprodukten
PT1235579E (pt) Composicoes farmaceuticas contendo trimegestona
EE200000625A (et) Atsetüülkoliinkoostiste stabiliseerimise meetodidja koostised
ATE293964T1 (de) Zusammensetzungen und verfahren zur behinderung der entladung von nematokyste
MXPA03001455A (es) Compuestos de pirazol, composiciones farmaceuticas y metodos para modular o inhibir la actividad del amiloide-beta-peptido asociado a reticulo endoplasmico y l-3-hidroxiacil-coa-deshidrogenasa.
RU94046300A (ru) Химические соединения, способ их получения, фармкомпозиция, способ лечения, промежуточный продукт
DE69626544T2 (de) Arzneistoffe
GEP20084346B (en) Protein kinase c inhibitors
EA200400409A1 (ru) Новые соединения изохинолина, способ их получения и фармацевтические композиции, содержащие их
WO1999025327A3 (en) Small molecule intervention in hiv-1 replication
DE60104822D1 (de) Pseudopolymorph von (-)-cis-2-(2-chlorphenyl)-5,7-dihydroxy-8[4r-(3s-hydroxy-1-methyl)piperidinyl]-4h-1-benzopyran-4-on hydrochlorid

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20110427